Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 22

1.

A near infrared fluorescent probe based on ICT for monitoring mitophagy in living cells.

Tang W, Dai Y, Gu B, Liu M, Yi Z, Li Z, Zhang Z, He H, Zeng R.

Analyst. 2020 Feb 17;145(4):1427-1432. doi: 10.1039/c9an02053e.

PMID:
31850403
2.

CAPS1 Suppresses Tumorigenesis in Cholangiocarcinoma.

Weng S, Janssen HLA, Zhang N, Tang W, Bai E, Yang B, Dong L.

Dig Dis Sci. 2019 Sep 27. doi: 10.1007/s10620-019-05843-9. [Epub ahead of print]

PMID:
31562609
3.

Molecular design and optimization of hepatic cancer SLP76-derived PLCγ1 SH3-binding peptide with the systematic N-substitution of peptide PXXP motif.

Tang W, Zhao Z, Wang C, Ye T, Yang B.

J Mol Recognit. 2019 Dec;32(12):e2806. doi: 10.1002/jmr.2806. Epub 2019 Aug 8.

PMID:
31397025
4.

TREM2 acts as a tumor suppressor in hepatocellular carcinoma by targeting the PI3K/Akt/β-catenin pathway.

Tang W, Lv B, Yang B, Chen Y, Yuan F, Ma L, Chen S, Zhang S, Xia J.

Oncogenesis. 2019 Jan 25;8(2):9. doi: 10.1038/s41389-018-0115-x.

5.

Oncogenic role of phospholipase C-γ1 in progression of hepatocellular carcinoma.

Tang W, Zhou Y, Sun D, Dong L, Xia J, Yang B.

Hepatol Res. 2019 May;49(5):559-569. doi: 10.1111/hepr.13309. Epub 2019 Feb 20. Erratum in: Hepatol Res. 2019 Sep;49(9):1088.

PMID:
30623526
6.

BH3 Mimetic ABT-199 Enhances the Sensitivity of Gemcitabine in Pancreatic Cancer in vitro and in vivo.

Zhou Y, Liu H, Xue R, Tang W, Zhang S.

Dig Dis Sci. 2018 Dec;63(12):3367-3375. doi: 10.1007/s10620-018-5253-7. Epub 2018 Aug 29.

PMID:
30155839
7.

FXR Acts as a Metastasis Suppressor in Intrahepatic Cholangiocarcinoma by Inhibiting IL-6-Induced Epithelial-Mesenchymal Transition.

Lv B, Ma L, Tang W, Huang P, Yang B, Wang L, Chen S, Gao Q, Zhang S, Xia J.

Cell Physiol Biochem. 2018;48(1):158-172. doi: 10.1159/000491715. Epub 2018 Jul 12.

8.

Spermine oxidase is upregulated and promotes tumor growth in hepatocellular carcinoma.

Hu T, Sun D, Zhang J, Xue R, Janssen HLA, Tang W, Dong L.

Hepatol Res. 2018 Nov;48(12):967-977. doi: 10.1111/hepr.13206. Epub 2018 Jul 27.

PMID:
29923661
9.

Dynamic network biomarker indicates pulmonary metastasis at the tipping point of hepatocellular carcinoma.

Yang B, Li M, Tang W, Liu W, Zhang S, Chen L, Xia J.

Nat Commun. 2018 Feb 14;9(1):678. doi: 10.1038/s41467-018-03024-2.

10.

Pro-inflammation NF-κB signaling triggers a positive feedback via enhancing cholesterol accumulation in liver cancer cells.

He M, Zhang W, Dong Y, Wang L, Fang T, Tang W, Lv B, Chen G, Yang B, Huang P, Xia J.

J Exp Clin Cancer Res. 2017 Jan 18;36(1):15. doi: 10.1186/s13046-017-0490-8.

11.

CAPS1 Negatively Regulates Hepatocellular Carcinoma Development through Alteration of Exocytosis-Associated Tumor Microenvironment.

Xue R, Tang W, Dong P, Weng S, Ma L, Chen S, Liu T, Shen X, Huang X, Zhang S, Dong L.

Int J Mol Sci. 2016 Sep 27;17(10). pii: E1626.

12.

Hepatocellular Carcinoma Cells Induce Regulatory T Cells and Lead to Poor Prognosis via Production of Transforming Growth Factor-β1.

Wang Y, Liu T, Tang W, Deng B, Chen Y, Zhu J, Shen X.

Cell Physiol Biochem. 2016;38(1):306-18. doi: 10.1159/000438631. Epub 2016 Jan 25.

13.

Caveolin-1 Confers Resistance of Hepatoma Cells to Anoikis by Activating IGF-1 Pathway.

Tang W, Feng X, Zhang S, Ren Z, Liu Y, Yang B, lv B, Cai Y, Xia J, Ge N.

Cell Physiol Biochem. 2015;36(3):1223-36. doi: 10.1159/000430292. Epub 2015 Jun 30.

14.

Overexpression of BIRC6 Is a Predictor of Prognosis for Colorectal Cancer.

Hu T, Weng S, Tang W, Xue R, Chen S, Cai G, Cai Y, Shen X, Zhang S, Dong L.

PLoS One. 2015 May 1;10(5):e0125281. doi: 10.1371/journal.pone.0125281. eCollection 2015.

15.

HIF-1α plays a role in the chemotactic migration of hepatocarcinoma cells through the modulation of CXCL6 expression.

Tian H, Huang P, Zhao Z, Tang W, Xia J.

Cell Physiol Biochem. 2014;34(5):1536-46. doi: 10.1159/000366357. Epub 2014 Oct 10.

16.

Apollon modulates chemosensitivity in human esophageal squamous cell carcinoma.

Zhang S, Tang W, Weng S, Liu X, Rao B, Gu J, Chen S, Wang Q, Shen X, Xue R, Dong L.

Oncotarget. 2014 Aug 30;5(16):7183-97.

17.

BIRC6 promotes hepatocellular carcinogenesis: interaction of BIRC6 with p53 facilitating p53 degradation.

Tang W, Xue R, Weng S, Wu J, Fang Y, Wang Y, Ji L, Hu T, Liu T, Huang X, Chen S, Shen X, Zhang S, Dong L.

Int J Cancer. 2015 Mar 15;136(6):E475-87. doi: 10.1002/ijc.29194. Epub 2014 Sep 18.

18.

Role of lamivudine with transarterial chemoembolization in the survival of patients with hepatocellular carcinoma.

Xu X, Huang P, Tian H, Chen Y, Ge N, Tang W, Yang B, Xia J.

J Gastroenterol Hepatol. 2014 Jun;29(6):1273-8. Erratum in: J Gastroenterol Hepatol. 2014 Oct;29(10):1848. Tang, Wengquing [corrected to Tang, Wenqing].

PMID:
24955456
19.

Toll like receptor 2 knock-out attenuates carbon tetrachloride (CCl4)-induced liver fibrosis by downregulating MAPK and NF-κB signaling pathways.

Ji L, Xue R, Tang W, Wu W, Hu T, Liu X, Peng X, Gu J, Chen S, Zhang S.

FEBS Lett. 2014 Jun 5;588(12):2095-100. doi: 10.1016/j.febslet.2014.04.042. Epub 2014 May 8.

20.

Direct interaction between surface β1,4-galactosyltransferase 1 and epidermal growth factor receptor (EGFR) inhibits EGFR activation in hepatocellular carcinoma.

Tang W, Weng S, Zhang S, Wu W, Dong L, Shen X, Zhang S, Gu J, Xue R.

Biochem Biophys Res Commun. 2013 May 10;434(3):449-54. doi: 10.1016/j.bbrc.2013.03.094. Epub 2013 Apr 10.

PMID:
23583406

Supplemental Content

Loading ...
Support Center